Amdocs Limited $DOX Shares Sold by Allianz Asset Management GmbH

Allianz Asset Management GmbH lessened its position in shares of Amdocs Limited (NASDAQ:DOX) by 12.3% in the third quarter, Holdings Channel.com reports. The fund owned 440,214 shares of the technology company’s stock after selling 61,595 shares during the quarter. Allianz Asset Management GmbH’s holdings in Amdocs were worth $36,120,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. Running Oak Capital LLC raised its holdings in shares of Amdocs by 4.6% in the 3rd quarter. Running Oak Capital LLC now owns 183,194 shares of the technology company’s stock worth $15,084,000 after purchasing an additional 8,071 shares during the period. Jackson Creek Investment Advisors LLC acquired a new stake in Amdocs during the 3rd quarter worth approximately $454,000. Atlantic Union Bankshares Corp purchased a new position in Amdocs in the third quarter valued at approximately $37,000. AGF Management Ltd. lifted its position in Amdocs by 16.8% during the third quarter. AGF Management Ltd. now owns 38,102 shares of the technology company’s stock valued at $3,126,000 after buying an additional 5,478 shares in the last quarter. Finally, Jones Financial Companies Lllp grew its stake in Amdocs by 17.3% during the third quarter. Jones Financial Companies Lllp now owns 1,468 shares of the technology company’s stock worth $120,000 after buying an additional 216 shares during the period. 92.02% of the stock is currently owned by hedge funds and other institutional investors.

Amdocs Stock Down 2.6%

Shares of Amdocs stock opened at $71.13 on Friday. Amdocs Limited has a 1-year low of $70.24 and a 1-year high of $95.41. The company has a market capitalization of $7.68 billion, a PE ratio of 13.76, a P/E/G ratio of 1.24 and a beta of 0.40. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.17 and a quick ratio of 1.17. The business has a 50-day moving average of $80.21 and a 200-day moving average of $82.49.

Amdocs (NASDAQ:DOX) last issued its quarterly earnings results on Tuesday, February 3rd. The technology company reported $1.81 EPS for the quarter, beating analysts’ consensus estimates of $1.75 by $0.06. Amdocs had a return on equity of 20.13% and a net margin of 12.47%.The firm had revenue of $1.16 billion during the quarter, compared to the consensus estimate of $1.15 billion. During the same quarter in the prior year, the business posted $1.66 earnings per share. Amdocs’s revenue for the quarter was up 4.1% on a year-over-year basis. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. As a group, equities analysts forecast that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Tuesday, March 31st will be given a dividend of $0.569 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This is an increase from Amdocs’s previous quarterly dividend of $0.53. This represents a $2.28 dividend on an annualized basis and a dividend yield of 3.2%. Amdocs’s dividend payout ratio is 40.81%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on DOX shares. Stifel Nicolaus cut their target price on shares of Amdocs from $97.00 to $88.00 and set a “buy” rating on the stock in a research note on Wednesday. Weiss Ratings reissued a “hold (c)” rating on shares of Amdocs in a research report on Tuesday, January 27th. Wolfe Research restated a “peer perform” rating on shares of Amdocs in a research note on Thursday, November 13th. Bank of America lowered their target price on Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research note on Wednesday, November 12th. Finally, Barclays dropped their target price on Amdocs from $111.00 to $92.00 and set an “overweight” rating on the stock in a report on Wednesday. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $92.33.

Trending Headlines about Amdocs

Here are the key news stories impacting Amdocs this week:

• Positive Sentiment: Q1 results beat consensus: Amdocs reported Q1 FY2026 EPS and revenue slightly above estimates with revenue up year‑over‑year, and management highlighted growth initiatives (including telco AI work and a T‑Mobile deal) that support longer‑term revenue expansion. Q1 beat article
• Positive Sentiment: Dividend hike: Amdocs raised its quarterly dividend ~8% to $0.569, lifting the yield to roughly 3.1%, which supports income investors and signals board confidence in cash flow. (Company announcement)
• Neutral Sentiment: Analyst action — Stifel keeps a Buy rating but trims the price target (from $97 to $88). That reflects continued analyst conviction in the business while acknowledging nearer‑term headwinds. Stifel note
• Neutral Sentiment: CEO succession announced: Long‑time CEO Shuky Sheffer will retire March 31; Shimie Hortig is named successor. Leadership transition introduces execution risk but also a clear succession plan. CEO appointment
• Negative Sentiment: Guidance / outlook reaction: Management’s forward commentary and updated 2026 outlook prompted a sharper market reaction than the quarter itself — investors sold into the mixed print because near‑term guidance cadence and margin/booking details were viewed as disappointing. Guidance reaction
• Negative Sentiment: Price action and downside momentum: Coverage noted the stock hitting a new 12‑month low after the post‑earnings move, signaling short‑term bearish momentum and higher volatility risk for holders. 12‑month low report
• Neutral Sentiment: Analyst / media takeaways: Several writeups emphasize “the good and the bad” — beat and strategic initiatives vs. near‑term guidance/leadership transition — leaving the setup as a classic tradeoff between near‑term risk and longer‑term catalysts. Seeking Alpha analysis

About Amdocs

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.